The effectiveness of phenylephrine for cold was rejected following studies showing that the decongestant had no health benefits.
Effectiveness of Phenylephrine for Cold Rejected After Studies Prove That It Doesn’t Work to Treat Common Cold and Nasal Congestion
The effectiveness of phenylephrine for cold was rejected despite increasing sales following studies proving that the decongestant was not helpful in treating common colds, nasal congestion, or other allergies, rejecting the effectiveness of phenylephrine for cold.
According to a report published in Roll Call, people have believed that using phenylephrine for cold, such as Dimetapp, was effective, which led to the increasing sales of the drugs, but after studies proved that phenylephrine for cold does not have health benefits, there might be decreased in its sales.
The effectiveness of phenylephrine for cold was once questioned in 2007; however, the Food and Drug Administration refused to remove phenylephrine for cold in the market at that time as studies of its effectiveness were ongoing and might negatively impact various manufacturers.
READ ALSO: First Generic Vyvanse 2023 Approved Amidst Increasing Cases Of ADHD Medication Drug Shortage
Phenylephrine for Cold Could Be Removed from Market Due to Its Effectiveness
After studies proved that phenylephrine for cold is ineffective, the Consumer Healthcare Products Association claimed that the decongestant was effective and safe based on the consumers who bought the common cold medicine.
Despite the effectiveness claims, phenylephrine for cold could be removed from the market because the FDA believed that everyone deserved to have safe and effective medications, CNBC reported.
READ ALSO: Drug Price Negotiation Brings Insulin And More Under Scrutiny For Savings